色素沈着症治療市場の2030年までの予測：タイプ別、適応症別、エンドユーザー別、地域別の世界分析

Stratistics MRCによると、世界の色素沈着症治療市場は2023年に47億8,000万米ドルを占め、予測期間中にCAGR 10.5％で成長し、2030年には96億1,000万米ドルに達する見込みです。

色素沈着という用語は、メラニン（皮膚に色を与える色素）の過剰によって引き起こされる、特定の肌色領域の黒ずみを表しています。ホルモン、紫外線暴露、炎症、皮膚外傷など、多くのことが色素沈着に関与している可能性があります。色素沈着症治療の主な目的は、通常、肌の色調を平らにし、過剰な色素を最小限に抑えるか除去することです。

2022年4月に発表されたAesthetic Plastic Surgery National Databankによると、米国では2021年にケミカルピーリング、ハイドロフェイシャルなどの皮膚治療が1,390,149件、コンビネーションレーザーが431,485件行われています。

皮膚の健康に対する意識の高まり

皮膚の健康に対する理解が深まるにつれ、人々は皮膚の劣化に対する予防策を採用するようになります。これには、日焼け止めの使用、防護服の着用、日陰の確保など、日焼けによる色素沈着に対する予防策が含まれます。包括的な皮膚の健康計画の実施は、色素沈着に関連する疾患の早期診断と治療を提唱します。人々は色素沈着の問題が生じると、すぐに専門家のアドバイスや治療を求める傾向が強くなります。セルフケアの文化は、皮膚の健康に対する認識によって育まれます。人々は、色素沈着をターゲットとしたスキンケアを定期的に行い、肌の健康全般を増進させる可能性が高くなります。

製品の安全性と副作用

顧客は、製品の悪影響によって心理的・肉体的に苦しむかもしれないです。火傷、肌荒れ、アレルギー反応、色素沈着の増加などです。治療を受けている人にとって、こうした副作用は痛み、不快感、不安を引き起こすかもしれないです。色素沈着症治療で否定的な副作用に見舞われると、顧客は製品やサービスに対する信頼を失う。嫌な経験をした人は、その会社やサービスに懐疑的になり、さらに治療を求めることに消極的になるかもしれないです。製品回収、法的措置、規制措置は、市場成長の妨げとなる深刻な安全性への懸念から生じる可能性があります。

文化的・美容的基準の高まり

多くの文化や地域が異なる美の基準を持っており、清潔でバランスの取れた、輝くような肌もそのひとつであることが多いです。市場における商品やサービスの入手可能性や色素沈着症治療に対する需要は、こうした基準によって大きな影響を受ける可能性があります。美的および化粧品の選択は、美に対する文化的な理想にも影響されます。肌を明るくしたり、明るくしたりするスキンケアや化粧品の製品は特定の地域で人気があり、色素沈着に対処することが多いです。

偽造品や規格外品

粗悪品や偽造品には、顧客の健康を危険にさらす危険な物質や隠れた物質が含まれている可能性があります。これらの製品は、皮膚の炎症、アレルギー反応、火傷、または既存の色素沈着障害の悪化により、身体的な傷害や苦痛を引き起こす可能性があります。粗悪品や偽造品を購入した顧客は、金銭的損害を被る可能性があります。頻繁に安価で販売されているこれらの商品について、顧客は節約できるという約束に誘われて購入するかもしれないです。しかし、その後、その製品が有害であるか、役に立たないことが判明する可能性があり、その場合、金銭が失われるため、市場に支障をきたすことになります。

COVID-19の影響

封鎖や安全上の懸念から、流行の初期には多くの皮膚科クリニックやメディカル・スパが一時閉鎖や営業時間の制限を余儀なくされました。その結果、色素沈着症治療の予約はキャンセルまたは延期されました。患者は病院を受診したがらなかったため、診療所が再開しても、予約患者は少なかっています。一部の患者は、色素沈着の治療を含む選択的手術を延期する決断を下しました。多くの皮膚科医やスキンケア専門医は、状況の変化に対応する方法として、バーチャル診察や遠隔医療サービスを提供し始めました。これにより、患者ケアの継続性はある程度可能になったが、対面での診察が必要な治療法にとっては困難も生じた。

予測期間中、レーザー治療分野が最大となる見込み

色素沈着症治療はレーザー治療が主流であり、さまざまなタイプの色素沈着を治療する最良の方法の1つと広くみなされていることから、レーザー治療セグメントは有利な成長を遂げると推定されます。レーザー技術を用いて皮膚の余分なメラニンを狙い撃ちし、分解することで、濃いシミを目立たなくし、より均一な肌色にすることができます。スキンケアとレーザー技術の科学は常に進化しており、より安全で効率的な色素沈着レーザー治療の提供に役立っています。

スキンクリニック分野は予測期間中に最も高いCAGRが見込まれる

スキンクリニックは色素沈着の治療を頻繁に行うため、予測期間中、スキンクリニック分野は最も高いCAGR成長が見込まれます。色素沈着を含む様々な皮膚疾患の特定と管理を専門とする皮膚科専門医やスキンケア専門医がこれらのクリニックで働いています。評価に基づいて、医療専門家は、1つまたは複数の治療アプローチを含むことができるカスタマイズされた治療プログラムを作成します。最新かつ効率的な治療法を患者に提供することを保証するため、皮膚科クリニックのスキンケア専門医は、皮膚科学とスキンケア科学における最新の進歩を常に把握しています。

最大のシェアを占める地域：

アジア太平洋地域は、西洋的な美の理想、より多くの可処分所得、スキンケアに関する知識の増加がこの市場拡大を促進する要因のいくつかであるため、予測期間中に最大の市場シェアを占めると予測されています。アジア太平洋地域では、日光への過剰な露出が色素沈着の主な原因となっています。そのため、日焼け止めクリームを使用し、日光から身を守ることがより重要になっています。さらに、皮膚科的処置への関心の高まりと皮膚の健康に対する意識の高まりにより、色素沈着症市場は拡大しています。

CAGRが最も高い地域：

北米は予測期間中に最も高いCAGRを示すと予測されます。これは、IPL（Intense Pulsed Light）療法、Qスイッチレーザー、フラクショナルレーザー、その他のレーザー治療が、皮膚科医やスキンケアの専門家によって、過剰なメラニンをターゲットにして分解するために使用されているためです。北米には、スキンケア施設、メディカル・スパ、皮膚科クリニックが数多くあり、最先端の機器を備え、色素沈着症治療の専門知識を有する有資格の専門家が常駐しています。さらに、黒点、老人斑、肝斑、炎症後色素沈着（PIH）などは、北米市場で扱われている色素沈着の形態のひとつです。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• エンドユーザー分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の色素沈着症治療市場：タイプ別

• レーザー治療
• ケミカルピーリングと漂白剤
• 薬物療法
• マイクロダーマブレーション
• 皮膚移植または形成外科
• 光線療法
• 化粧品
• その他のタイプ

第6章 世界の色素沈着症治療市場：適応症別

• 白斑
• 肝斑
• アルビノ
• 炎症後色素沈着過剰症（PIH）
• その他の適応症

第7章 世界の色素沈着症治療市場：エンドユーザー別

• ドラッグストアと化粧品店
• 皮膚科クリニック
• ハイパーマーケットとスーパーマーケット
• スパ
• その他のエンドユーザー

第8章 世界の色素沈着症治療市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第9章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第10章 企業プロファイル

• AbbVie Inc.
• Astellas Pharma Inc.
• Bausch Health Companies Inc
• Candela Corporation
• DermaMed Solutions LLC
• Dermavant Science Inc.
• Dr. Reddy's Laboratories Limited
• Epionce
• Galderma SA
• Alvogen
• Glenmark Pharmaceuticals Limited
• Incyte Corporation
• L'Oreal SA
• Merz GmbH & Co. KGaA
• Obagi Cosmeceuticals LLC
• Pfizer Inc.
• Pierre Fabre Group
• SkinCeuticals
• Viatirs Inc.（Mylan N.V.）
• Vital Esthetique

List of Tables

• Table 1 Global Hyperpigmentation Treatment Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Hyperpigmentation Treatment Market Outlook, By Type (2021-2030) ($MN)
• Table 3 Global Hyperpigmentation Treatment Market Outlook, By Laser Treatment (2021-2030) ($MN)
• Table 4 Global Hyperpigmentation Treatment Market Outlook, By Chemical Peels and Bleach (2021-2030) ($MN)
• Table 5 Global Hyperpigmentation Treatment Market Outlook, By Pharmacological Therapy (2021-2030) ($MN)
• Table 6 Global Hyperpigmentation Treatment Market Outlook, By Microdermabrasion (2021-2030) ($MN)
• Table 7 Global Hyperpigmentation Treatment Market Outlook, By Skin Grafting or Plastic Surgery (2021-2030) ($MN)
• Table 8 Global Hyperpigmentation Treatment Market Outlook, By Phototherapy (2021-2030) ($MN)
• Table 9 Global Hyperpigmentation Treatment Market Outlook, By Cosmeceuticals (2021-2030) ($MN)
• Table 10 Global Hyperpigmentation Treatment Market Outlook, By Other Types (2021-2030) ($MN)
• Table 11 Global Hyperpigmentation Treatment Market Outlook, By Indication (2021-2030) ($MN)
• Table 12 Global Hyperpigmentation Treatment Market Outlook, By Vitiligo (2021-2030) ($MN)
• Table 13 Global Hyperpigmentation Treatment Market Outlook, By Melasma (2021-2030) ($MN)
• Table 14 Global Hyperpigmentation Treatment Market Outlook, By Albinism (2021-2030) ($MN)
• Table 15 Global Hyperpigmentation Treatment Market Outlook, By Post-inflammatory Hyperpigmentation (PIH) (2021-2030) ($MN)
• Table 16 Global Hyperpigmentation Treatment Market Outlook, By Other Indications (2021-2030) ($MN)
• Table 17 Global Hyperpigmentation Treatment Market Outlook, By End User (2021-2030) ($MN)
• Table 18 Global Hyperpigmentation Treatment Market Outlook, By Drug & Cosmetic Stores (2021-2030) ($MN)
• Table 19 Global Hyperpigmentation Treatment Market Outlook, By Skin Clinics (2021-2030) ($MN)
• Table 20 Global Hyperpigmentation Treatment Market Outlook, By Hypermarkets & Supermarkets (2021-2030) ($MN)
• Table 21 Global Hyperpigmentation Treatment Market Outlook, By Spas (2021-2030) ($MN)
• Table 22 Global Hyperpigmentation Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 23 North America Hyperpigmentation Treatment Market Outlook, By Country (2021-2030) ($MN)
• Table 24 North America Hyperpigmentation Treatment Market Outlook, By Type (2021-2030) ($MN)
• Table 25 North America Hyperpigmentation Treatment Market Outlook, By Laser Treatment (2021-2030) ($MN)
• Table 26 North America Hyperpigmentation Treatment Market Outlook, By Chemical Peels and Bleach (2021-2030) ($MN)
• Table 27 North America Hyperpigmentation Treatment Market Outlook, By Pharmacological Therapy (2021-2030) ($MN)
• Table 28 North America Hyperpigmentation Treatment Market Outlook, By Microdermabrasion (2021-2030) ($MN)
• Table 29 North America Hyperpigmentation Treatment Market Outlook, By Skin Grafting or Plastic Surgery (2021-2030) ($MN)
• Table 30 North America Hyperpigmentation Treatment Market Outlook, By Phototherapy (2021-2030) ($MN)
• Table 31 North America Hyperpigmentation Treatment Market Outlook, By Cosmeceuticals (2021-2030) ($MN)
• Table 32 North America Hyperpigmentation Treatment Market Outlook, By Other Types (2021-2030) ($MN)
• Table 33 North America Hyperpigmentation Treatment Market Outlook, By Indication (2021-2030) ($MN)
• Table 34 North America Hyperpigmentation Treatment Market Outlook, By Vitiligo (2021-2030) ($MN)
• Table 35 North America Hyperpigmentation Treatment Market Outlook, By Melasma (2021-2030) ($MN)
• Table 36 North America Hyperpigmentation Treatment Market Outlook, By Albinism (2021-2030) ($MN)
• Table 37 North America Hyperpigmentation Treatment Market Outlook, By Post-inflammatory Hyperpigmentation (PIH) (2021-2030) ($MN)
• Table 38 North America Hyperpigmentation Treatment Market Outlook, By Other Indications (2021-2030) ($MN)
• Table 39 North America Hyperpigmentation Treatment Market Outlook, By End User (2021-2030) ($MN)
• Table 40 North America Hyperpigmentation Treatment Market Outlook, By Drug & Cosmetic Stores (2021-2030) ($MN)
• Table 41 North America Hyperpigmentation Treatment Market Outlook, By Skin Clinics (2021-2030) ($MN)
• Table 42 North America Hyperpigmentation Treatment Market Outlook, By Hypermarkets & Supermarkets (2021-2030) ($MN)
• Table 43 North America Hyperpigmentation Treatment Market Outlook, By Spas (2021-2030) ($MN)
• Table 44 North America Hyperpigmentation Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 45 Europe Hyperpigmentation Treatment Market Outlook, By Country (2021-2030) ($MN)
• Table 46 Europe Hyperpigmentation Treatment Market Outlook, By Type (2021-2030) ($MN)
• Table 47 Europe Hyperpigmentation Treatment Market Outlook, By Laser Treatment (2021-2030) ($MN)
• Table 48 Europe Hyperpigmentation Treatment Market Outlook, By Chemical Peels and Bleach (2021-2030) ($MN)
• Table 49 Europe Hyperpigmentation Treatment Market Outlook, By Pharmacological Therapy (2021-2030) ($MN)
• Table 50 Europe Hyperpigmentation Treatment Market Outlook, By Microdermabrasion (2021-2030) ($MN)
• Table 51 Europe Hyperpigmentation Treatment Market Outlook, By Skin Grafting or Plastic Surgery (2021-2030) ($MN)
• Table 52 Europe Hyperpigmentation Treatment Market Outlook, By Phototherapy (2021-2030) ($MN)
• Table 53 Europe Hyperpigmentation Treatment Market Outlook, By Cosmeceuticals (2021-2030) ($MN)
• Table 54 Europe Hyperpigmentation Treatment Market Outlook, By Other Types (2021-2030) ($MN)
• Table 55 Europe Hyperpigmentation Treatment Market Outlook, By Indication (2021-2030) ($MN)
• Table 56 Europe Hyperpigmentation Treatment Market Outlook, By Vitiligo (2021-2030) ($MN)
• Table 57 Europe Hyperpigmentation Treatment Market Outlook, By Melasma (2021-2030) ($MN)
• Table 58 Europe Hyperpigmentation Treatment Market Outlook, By Albinism (2021-2030) ($MN)
• Table 59 Europe Hyperpigmentation Treatment Market Outlook, By Post-inflammatory Hyperpigmentation (PIH) (2021-2030) ($MN)
• Table 60 Europe Hyperpigmentation Treatment Market Outlook, By Other Indications (2021-2030) ($MN)
• Table 61 Europe Hyperpigmentation Treatment Market Outlook, By End User (2021-2030) ($MN)
• Table 62 Europe Hyperpigmentation Treatment Market Outlook, By Drug & Cosmetic Stores (2021-2030) ($MN)
• Table 63 Europe Hyperpigmentation Treatment Market Outlook, By Skin Clinics (2021-2030) ($MN)
• Table 64 Europe Hyperpigmentation Treatment Market Outlook, By Hypermarkets & Supermarkets (2021-2030) ($MN)
• Table 65 Europe Hyperpigmentation Treatment Market Outlook, By Spas (2021-2030) ($MN)
• Table 66 Europe Hyperpigmentation Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 67 Asia Pacific Hyperpigmentation Treatment Market Outlook, By Country (2021-2030) ($MN)
• Table 68 Asia Pacific Hyperpigmentation Treatment Market Outlook, By Type (2021-2030) ($MN)
• Table 69 Asia Pacific Hyperpigmentation Treatment Market Outlook, By Laser Treatment (2021-2030) ($MN)
• Table 70 Asia Pacific Hyperpigmentation Treatment Market Outlook, By Chemical Peels and Bleach (2021-2030) ($MN)
• Table 71 Asia Pacific Hyperpigmentation Treatment Market Outlook, By Pharmacological Therapy (2021-2030) ($MN)
• Table 72 Asia Pacific Hyperpigmentation Treatment Market Outlook, By Microdermabrasion (2021-2030) ($MN)
• Table 73 Asia Pacific Hyperpigmentation Treatment Market Outlook, By Skin Grafting or Plastic Surgery (2021-2030) ($MN)
• Table 74 Asia Pacific Hyperpigmentation Treatment Market Outlook, By Phototherapy (2021-2030) ($MN)
• Table 75 Asia Pacific Hyperpigmentation Treatment Market Outlook, By Cosmeceuticals (2021-2030) ($MN)
• Table 76 Asia Pacific Hyperpigmentation Treatment Market Outlook, By Other Types (2021-2030) ($MN)
• Table 77 Asia Pacific Hyperpigmentation Treatment Market Outlook, By Indication (2021-2030) ($MN)
• Table 78 Asia Pacific Hyperpigmentation Treatment Market Outlook, By Vitiligo (2021-2030) ($MN)
• Table 79 Asia Pacific Hyperpigmentation Treatment Market Outlook, By Melasma (2021-2030) ($MN)
• Table 80 Asia Pacific Hyperpigmentation Treatment Market Outlook, By Albinism (2021-2030) ($MN)
• Table 81 Asia Pacific Hyperpigmentation Treatment Market Outlook, By Post-inflammatory Hyperpigmentation (PIH) (2021-2030) ($MN)
• Table 82 Asia Pacific Hyperpigmentation Treatment Market Outlook, By Other Indications (2021-2030) ($MN)
• Table 83 Asia Pacific Hyperpigmentation Treatment Market Outlook, By End User (2021-2030) ($MN)
• Table 84 Asia Pacific Hyperpigmentation Treatment Market Outlook, By Drug & Cosmetic Stores (2021-2030) ($MN)
• Table 85 Asia Pacific Hyperpigmentation Treatment Market Outlook, By Skin Clinics (2021-2030) ($MN)
• Table 86 Asia Pacific Hyperpigmentation Treatment Market Outlook, By Hypermarkets & Supermarkets (2021-2030) ($MN)
• Table 87 Asia Pacific Hyperpigmentation Treatment Market Outlook, By Spas (2021-2030) ($MN)
• Table 88 Asia Pacific Hyperpigmentation Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 89 South America Hyperpigmentation Treatment Market Outlook, By Country (2021-2030) ($MN)
• Table 90 South America Hyperpigmentation Treatment Market Outlook, By Type (2021-2030) ($MN)
• Table 91 South America Hyperpigmentation Treatment Market Outlook, By Laser Treatment (2021-2030) ($MN)
• Table 92 South America Hyperpigmentation Treatment Market Outlook, By Chemical Peels and Bleach (2021-2030) ($MN)
• Table 93 South America Hyperpigmentation Treatment Market Outlook, By Pharmacological Therapy (2021-2030) ($MN)
• Table 94 South America Hyperpigmentation Treatment Market Outlook, By Microdermabrasion (2021-2030) ($MN)
• Table 95 South America Hyperpigmentation Treatment Market Outlook, By Skin Grafting or Plastic Surgery (2021-2030) ($MN)
• Table 96 South America Hyperpigmentation Treatment Market Outlook, By Phototherapy (2021-2030) ($MN)
• Table 97 South America Hyperpigmentation Treatment Market Outlook, By Cosmeceuticals (2021-2030) ($MN)
• Table 98 South America Hyperpigmentation Treatment Market Outlook, By Other Types (2021-2030) ($MN)
• Table 99 South America Hyperpigmentation Treatment Market Outlook, By Indication (2021-2030) ($MN)
• Table 100 South America Hyperpigmentation Treatment Market Outlook, By Vitiligo (2021-2030) ($MN)
• Table 101 South America Hyperpigmentation Treatment Market Outlook, By Melasma (2021-2030) ($MN)
• Table 102 South America Hyperpigmentation Treatment Market Outlook, By Albinism (2021-2030) ($MN)
• Table 103 South America Hyperpigmentation Treatment Market Outlook, By Post-inflammatory Hyperpigmentation (PIH) (2021-2030) ($MN)
• Table 104 South America Hyperpigmentation Treatment Market Outlook, By Other Indications (2021-2030) ($MN)
• Table 105 South America Hyperpigmentation Treatment Market Outlook, By End User (2021-2030) ($MN)
• Table 106 South America Hyperpigmentation Treatment Market Outlook, By Drug & Cosmetic Stores (2021-2030) ($MN)
• Table 107 South America Hyperpigmentation Treatment Market Outlook, By Skin Clinics (2021-2030) ($MN)
• Table 108 South America Hyperpigmentation Treatment Market Outlook, By Hypermarkets & Supermarkets (2021-2030) ($MN)
• Table 109 South America Hyperpigmentation Treatment Market Outlook, By Spas (2021-2030) ($MN)
• Table 110 South America Hyperpigmentation Treatment Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 111 Middle East & Africa Hyperpigmentation Treatment Market Outlook, By Country (2021-2030) ($MN)
• Table 112 Middle East & Africa Hyperpigmentation Treatment Market Outlook, By Type (2021-2030) ($MN)
• Table 113 Middle East & Africa Hyperpigmentation Treatment Market Outlook, By Laser Treatment (2021-2030) ($MN)
• Table 114 Middle East & Africa Hyperpigmentation Treatment Market Outlook, By Chemical Peels and Bleach (2021-2030) ($MN)
• Table 115 Middle East & Africa Hyperpigmentation Treatment Market Outlook, By Pharmacological Therapy (2021-2030) ($MN)
• Table 116 Middle East & Africa Hyperpigmentation Treatment Market Outlook, By Microdermabrasion (2021-2030) ($MN)
• Table 117 Middle East & Africa Hyperpigmentation Treatment Market Outlook, By Skin Grafting or Plastic Surgery (2021-2030) ($MN)
• Table 118 Middle East & Africa Hyperpigmentation Treatment Market Outlook, By Phototherapy (2021-2030) ($MN)
• Table 119 Middle East & Africa Hyperpigmentation Treatment Market Outlook, By Cosmeceuticals (2021-2030) ($MN)
• Table 120 Middle East & Africa Hyperpigmentation Treatment Market Outlook, By Other Types (2021-2030) ($MN)
• Table 121 Middle East & Africa Hyperpigmentation Treatment Market Outlook, By Indication (2021-2030) ($MN)
• Table 122 Middle East & Africa Hyperpigmentation Treatment Market Outlook, By Vitiligo (2021-2030) ($MN)
• Table 123 Middle East & Africa Hyperpigmentation Treatment Market Outlook, By Melasma (2021-2030) ($MN)
• Table 124 Middle East & Africa Hyperpigmentation Treatment Market Outlook, By Albinism (2021-2030) ($MN)
• Table 125 Middle East & Africa Hyperpigmentation Treatment Market Outlook, By Post-inflammatory Hyperpigmentation (PIH) (2021-2030) ($MN)
• Table 126 Middle East & Africa Hyperpigmentation Treatment Market Outlook, By Other Indications (2021-2030) ($MN)
• Table 127 Middle East & Africa Hyperpigmentation Treatment Market Outlook, By End User (2021-2030) ($MN)
• Table 128 Middle East & Africa Hyperpigmentation Treatment Market Outlook, By Drug & Cosmetic Stores (2021-2030) ($MN)
• Table 129 Middle East & Africa Hyperpigmentation Treatment Market Outlook, By Skin Clinics (2021-2030) ($MN)
• Table 130 Middle East & Africa Hyperpigmentation Treatment Market Outlook, By Hypermarkets & Supermarkets (2021-2030) ($MN)
• Table 131 Middle East & Africa Hyperpigmentation Treatment Market Outlook, By Spas (2021-2030) ($MN)
• Table 132 Middle East & Africa Hyperpigmentation Treatment Market Outlook, By Other End Users (2021-2030) ($MN)

According to Stratistics MRC, the Global Hyperpigmentation Treatment Market is accounted for $4.78 billion in 2023 and is expected to reach $9.61 billion by 2030 growing at a CAGR of 10.5% during the forecast period. The term "hyperpigmentation" describes the darkening of certain skin tone regions brought on by an excess of melanin, the pigment that gives skin its color. Numerous things, such as hormones, UV exposure, inflammation, and skin traumas, might contribute to it. The main goals of hyperpigmentation treatments are usually to level out the skin tone and minimize or remove excess pigment.

According to the Aesthetic Plastic Surgery National Databank published in April 2022, 1,390,149 skin treatment procedures, including chemical peels, hydro facials, and others, and 431,485 combination lasers were performed in the United States in 2021

Market Dynamics:

Driver:

Increased skin health awareness

A greater understanding of skin health motivates people to adopt preventative measures against skin deterioration. This involves taking precautions against sun-induced hyperpigmentation, such as using sunscreen, dressing in protective clothes, and finding shade. The implementation of a comprehensive skin health plan advocates for the early diagnosis and treatment of disorders related to hyperpigmentation. People are more inclined to seek expert advice and treatment as soon as hyperpigmentation problems arise. A culture of self-care is fostered by awareness of skin health. People are more likely to follow regular skincare regimens that target hyperpigmentation and enhance the general health of their skin.

Restraint:

Product safety and adverse effects

Customers may suffer psychologically and physically from a product's adverse impacts. There might be burns, skin irritation, allergic responses, or increasing hyperpigmentation. For those pursuing therapy, these side effects may cause pain, discomfort, and concern. Customers lose faith in a product or service when they suffer negative side effects from hyperpigmentation treatments. People who have had bad encounters may become skeptical of the company or service and be reluctant to seek out more care. Product recalls, legal action, and regulatory actions might result from serious safety concerns which hinder the market growth.

Opportunity:

Growing cultural and beauty standards

Many cultures and geographical areas have different standards of beauty, and clean, balanced, and glowing skins are frequently among them. The market's availability of goods and services, as well as the demand for hyperpigmentation treatments, may be significantly impacted by these criteria. Aesthetic and cosmetic choices are also influenced by cultural ideals of beauty. Products for skincare and cosmetics that brighten or lighten the skin are popular in specific areas and frequently address hyperpigmentation.

Threat:

Counterfeit and substandard products

Products that are subpar or counterfeit may have dangerous or hidden substances that put customers' health at risk. These products have the potential to cause bodily injury and suffering due to skin irritations, allergic reactions, burns, or exacerbation of pre-existing hyperpigmentation disorders. Customers that purchase inferior or counterfeit goods may suffer financial damages. The promise of savings may entice customers to purchase these items, which are frequently sold at reduced costs. They could subsequently discover, though, that the product is hazardous or useless, in which case money would be lost thus impedes the market.

COVID-19 Impact

Due to lockdowns and safety concerns, numerous dermatological clinics and medical spas had to temporarily close or restrict their operational hours during the early phases of the epidemic. As a result, appointments for hyperpigmentation treatments were either cancelled or postponed. Patients were reluctant to visit hospitals, thus even once clinics reopened, fewer individuals were scheduled for appointments. Certain patients made the decision to postpone elective operations, including as treatments for hyperpigmentation. Many dermatologists and skincare specialists started providing virtual consultations and telemedicine services as a way to adjust to the changing circumstances. This made some continuity in patient care possible, but also presented difficulties for therapies that call for in-person consultations.

The laser treatment segment is expected to be the largest during the forecast period

The laser treatment segment is estimated to have a lucrative growth, as the hyperpigmentation treatments is dominated by laser therapy, which is widely regarded as one of the best methods for treating different types of hyperpigmentation. Dark spots can be less noticeable and a more uniform skin tone can be attained by using laser technology to target and break down excess melanin in the skin. The science of skincare and laser technology is always evolving, which helps to provide safer and more efficient laser treatments for hyperpigmentation thus driving the market.

The skin clinics segment is expected to have the highest CAGR during the forecast period

The skin clinics segment is anticipated to witness the highest CAGR growth during the forecast period, as Skin clinics frequently provide therapy for hyperpigmentation. Expert dermatologists and skincare specialists, who specialize in identifying and managing a variety of skin disorders, including hyperpigmentation, work in these clinics. Drawing on the evaluation, the medical professional will create a customized treatment program that can involve one or more therapy approaches. To guarantee that they are offering patients the most modern and efficient treatment alternatives, skincare specialists in skin clinics keep up to date on the most recent advancements in dermatology and skincare science.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period due to western beauty ideals, more disposable wealth, and growing knowledge of skincare are some of the factors driving this expansion. Overexposure to the sun is a major cause of hyperpigmentation in the Asia Pacific area. As a result, using sunscreen creams and protecting oneself from the sun are now more important. Moreover, due to rising interest in dermatological procedures and rising awareness of skin health the market for hyperpigmentation market is growing.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to Intense pulsed light (IPL) therapy, Q-switched lasers, fractional lasers, and other laser treatments are used by dermatologists and skincare specialists to target and breakdown excess melanin. North America is home to a sizable number of skincare facilities, medical spas, and dermatological clinics that are stocked with cutting-edge equipment and manned by qualified specialists with expertise in treating hyperpigmentation. In addition Sunspots, age spots, melasma, and post-inflammatory hyperpigmentation (PIH) are among the several forms of hyperpigmentation that are addressed in the North American market.

Key players in the market

Some of the key players profiled in the Hyperpigmentation Treatment Market include: AbbVie Inc., Astellas Pharma Inc., Bausch Health Companies Inc, Candela Corporation, "DermaMed Solutions LLC, Dermavant Science Inc., Dr. Reddy's Laboratories Limited, Epionce, Galderma SA, Alvogen, Glenmark Pharmaceuticals Limited, Incyte Corporation, L'Oreal SA , Merz GmbH & Co. KGaA, Obagi Cosmeceuticals LLC, Pfizer Inc., Pierre Fabre Group, SkinCeuticals, Viatirs Inc. (Mylan N.V.) and Vital Esthetique

Key Developments:

In October 2023, AbbVie announced that its Phase 2b study evaluating upadacitinib (RINVOQ®) in adults with non-segmental vitiligo (NSV) met the primary endpoint of percent change from baseline in the Facial Vitiligo Area Scoring Index (F-VASI) at week 24 with the 11 mg and 22 mg doses versus placebo.

In October 2023, Astellas Pharma Inc. and BioLabs Global, Inc. and Mitsui Fudosan announced that they have agreed on a tri-party memorandum of understanding to enhance the life science ecosystem in Tsukuba and Kashiwa-no-ha, Japan, world-renowned science hubs.

In September 2023, Bausch + Lomb Corporation a subsidiary of Bausch Health Companies Inc. announced that, in connection with the financing of its pending acquisition of XIIDRA® and certain other ophthalmology assets, Bausch + Lomb Escrow Corp.

Types Covered:

• Laser Treatment
• Chemical Peels and Bleach
• Pharmacological Therapy
• Microdermabrasion
• Skin Grafting or Plastic Surgery
• Phototherapy
• Cosmeceuticals
• Other Types

Indications Covered:

• Vitiligo
• Melasma
• Albinism
• Post-inflammatory Hyperpigmentation (PIH)
• Other Indications

End Users Covered:

• Drug & Cosmetic Stores
• Skin Clinics
• Hypermarkets & Supermarkets
• Spas
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 End User Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Hyperpigmentation Treatment Market, By Type

• 5.1 Introduction
• 5.2 Laser Treatment
• 5.3 Chemical Peels and Bleach
• 5.4 Pharmacological Therapy
• 5.5 Microdermabrasion
• 5.6 Skin Grafting or Plastic Surgery
• 5.7 Phototherapy
• 5.8 Cosmeceuticals
• 5.9 Other Types

6 Global Hyperpigmentation Treatment Market, By Indication

• 6.1 Introduction
• 6.2 Vitiligo
• 6.3 Melasma
• 6.4 Albinism
• 6.5 Post-inflammatory Hyperpigmentation (PIH)
• 6.6 Other Indications

7 Global Hyperpigmentation Treatment Market, By End User

• 7.1 Introduction
• 7.2 Drug & Cosmetic Stores
• 7.3 Skin Clinics
• 7.4 Hypermarkets & Supermarkets
• 7.5 Spas
• 7.6 Other End Users

8 Global Hyperpigmentation Treatment Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 AbbVie Inc.
• 10.2 Astellas Pharma Inc.
• 10.3 Bausch Health Companies Inc
• 10.4 Candela Corporation
• 10.5 DermaMed Solutions LLC
• 10.6 Dermavant Science Inc.
• 10.7 Dr. Reddy's Laboratories Limited
• 10.8 Epionce
• 10.9 Galderma SA
• 10.10 Alvogen
• 10.11 Glenmark Pharmaceuticals Limited
• 10.12 Incyte Corporation
• 10.13 L'Oreal SA
• 10.14 Merz GmbH & Co. KGaA
• 10.15 Obagi Cosmeceuticals LLC
• 10.16 Pfizer Inc.
• 10.17 Pierre Fabre Group
• 10.18 SkinCeuticals
• 10.19 Viatirs Inc. (Mylan N.V.)
• 10.20 Vital Esthetique